<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01873716</url>
  </required_header>
  <id_info>
    <org_study_id>2012P000895</org_study_id>
    <nct_id>NCT01873716</nct_id>
  </id_info>
  <brief_title>Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque</brief_title>
  <acronym>BRIGHT-CEA</acronym>
  <official_title>Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque -- A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be a pilot study of 9 patients undergoing standard-of-care clinically indicated
      carotid endarterectomy. The nine patients will receive an injection of Indocyanine green
      (ICG) at a dose of 0.25 mg/kg (maximum 25 mg) as an intravenous bolus.

      Immediately following endarterectomy, the resected specimen will be immersed in normal
      saline. Ex vivo fluorescence reflectance imaging (FRI) and immunohistochemistry will be
      performed.

      The investigators hypothesize that compared to controls, ICG-injected patients will
      demonstrate increased ex vivo and microscopic ICG fluorescence signal within areas of plaque.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tissue uptake of indocyanine green in carotid plaque</measure>
    <time_frame>within 3 months after carotid endarterectomy</time_frame>
    <description>Characterize tissue distribution of indocyanine green in human carotid artery specimens after carotid endarterectomy using fluorescence microcopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relationship of indocyanine green uptake to carotid plaque histology</measure>
    <time_frame>within 3 months after carotid endarterectomy</time_frame>
    <description>Analysis of tissue distribution of indocyanine green in human carotid artery specimens after carotid endarterectomy using histopathology</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Atherosclerosis</condition>
  <condition>Atherosclerotic Plaque</condition>
  <condition>Carotid Stenosis</condition>
  <arm_group>
    <arm_group_label>Injection of Indocyanine Green</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of Indocyanine Green prior to carotid endarterectomy surgery. Collection of specimen during surgery with subsequent carotid tissue analysis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No injection</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No injection prior to carotid endarterectomy surgery. Collection of specimen during surgery with subsequent carotid tissue analysis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indocyanine green</intervention_name>
    <description>Indocyanine green (ICG) for injection, 0.25mg/kg intravenously. A maximum of 25mg is given, approximately 30-60 minutes before carotid endarterectomy</description>
    <arm_group_label>Injection of Indocyanine Green</arm_group_label>
    <other_name>FDA Application No. (ANDA) 040811</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Consecutive patients scheduled for elective carotid endarterectomy at Massachusetts
             General Hospital

          -  Age &gt; 18 years of age.

          -  Signed informed consent.

        Exclusion criteria:

          -  Hemodynamic instability

          -  Any history of iodide allergy

          -  Any history of renal failure (estimated Glomerular Filtration Rate (eGFR) &lt;50
             ml/min/1.73 m2)

          -  Any history of liver failure

          -  Any history of bleeding diathesis

          -  Any history of cerebral vascular accident in the preceding 3 months

          -  Pregnant or lactating females.

          -  Hx of seafood allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Farouc A Jaffer, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Vinegoni C, Botnaru I, Aikawa E, Calfon MA, Iwamoto Y, Folco EJ, Ntziachristos V, Weissleder R, Libby P, Jaffer FA. Indocyanine green enables near-infrared fluorescence imaging of lipid-rich, inflamed atherosclerotic plaques. Sci Transl Med. 2011 May 25;3(84):84ra45. doi: 10.1126/scitranslmed.3001577.</citation>
    <PMID>21613624</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2013</study_first_submitted>
  <study_first_submitted_qc>June 6, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2013</study_first_posted>
  <last_update_submitted>January 31, 2017</last_update_submitted>
  <last_update_submitted_qc>January 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Farouc Amin Jaffer</investigator_full_name>
    <investigator_title>Associate Professor of Medicine, Harvard Medical School</investigator_title>
  </responsible_party>
  <keyword>Atherosclerosis</keyword>
  <keyword>Molecular Imaging</keyword>
  <keyword>Vascular Biology</keyword>
  <keyword>Inflammation</keyword>
  <keyword>Fluorescence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Carotid Stenosis</mesh_term>
    <mesh_term>Plaque, Atherosclerotic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

